Alzheimer s Disease Theranostics

Produk Detail:
  • Author : Magisetty Obulesu
  • Publisher : Academic Press
  • Pages : 80 pages
  • ISBN : 0128167394
  • Rating : /5 from reviews
CLICK HERE TO GET THIS BOOK >>>Alzheimer s Disease Theranostics

Download or Read online Alzheimer s Disease Theranostics full in PDF, ePub and kindle. this book written by Magisetty Obulesu and published by Academic Press which was released on 20 January 2019 with total page 80 pages. We cannot guarantee that Alzheimer s Disease Theranostics book is available in the library, click Get Book button and read full online book in your kindle, tablet, IPAD, PC or mobile whenever and wherever You Like. Alzheimer’s Disease Theranostics discusses the latest information on recent theranostic avenues for both the diagnosis and treatment of Alzheimer’s patients. It presents the pros and cons of the probable mechanistic role of nanoparticles in crossing the blood-brain barrier and improving disease symptoms. Finally, it highlights the merits of existing maneuvers and suggests perspectives to aid in future developments. Despite the difficulty of drug delivery to the brain, there are some nanoparticulate platforms demonstrating promise in treating neurodegenerative disorders such as Alzheimer’s disease. Manifold theranostic maneuvers include antioxidants, natural bioactive compounds, gene therapy, and nanotechnological approaches, all of which are discussed in this important work. Examines various theranostic applications for the diagnosis and treatment of Alzheimer’s disease Features a comprehensive overview of nanoparticle therapeutics in the area and use of antioxidants Assesses the common challenges and lessons learned from blood-brain barrier challenges, viral vector approaches and mitochondria-targeted therapeutics

Alzheimer s Disease Theranostics

Alzheimer   s Disease Theranostics
  • Author : Magisetty Obulesu
  • Publisher : Academic Press
  • Release : 20 January 2019
GET THIS BOOK Alzheimer s Disease Theranostics

Alzheimer’s Disease Theranostics discusses the latest information on recent theranostic avenues for both the diagnosis and treatment of Alzheimer’s patients. It presents the pros and cons of the probable mechanistic role of nanoparticles in crossing the blood-brain barrier and improving disease symptoms. Finally, it highlights the merits of existing maneuvers and suggests perspectives to aid in future developments. Despite the difficulty of drug delivery to the brain, there are some nanoparticulate platforms demonstrating promise in treating neurodegenerative disorders

Nanotheranostics for Cancer Applications

Nanotheranostics for Cancer Applications
  • Author : Prakash Rai,Stephanie A. Morris
  • Publisher : Springer
  • Release : 12 November 2018
GET THIS BOOK Nanotheranostics for Cancer Applications

This book is the first to focus specifically on cancer nanotheranostics. Each of the chapters that make up this comprehensive volume is authored by a researcher, clinician, or regulatory agency member known for their expertise in this field. Theranostics, the technology to simultaneously diagnose and treat a disease, is a nascent field that is growing rapidly in this era of personalized medicine. As the need for cost-effective disease diagnosis grows, drug delivery systems that can act as multifunctional carriers for

Neurodegeneration and Alzheimer s Disease

Neurodegeneration and Alzheimer s Disease
  • Author : Ralph N. Martins,Charles S. Brennan
  • Publisher : Wiley
  • Release : 24 June 2019
GET THIS BOOK Neurodegeneration and Alzheimer s Disease

Understanding the impact of diet, exercise, genetics, and hormones on the risk and development of Alzheimer’s and other neurogenerative diseases Diet is widely known to impact on neurological function. Nevertheless, academic texts discussing this relationship are relatively few in number. This book therefore fills an important gap in the current literature. Opening with an overview of neurodegenerative diseases, particularly Alzheimer’s disease, the text then focuses on explaining the means by which glycemic control and lipid metabolism – and associated

Phytomedicine and Alzheimer s Disease

Phytomedicine and Alzheimer   s Disease
  • Author : Atanu Bhattacharjee,Akula Ramakrishna,M. Obulesu
  • Publisher : CRC Press
  • Release : 25 October 2020
GET THIS BOOK Phytomedicine and Alzheimer s Disease

Alzheimer's disease, one of the most rapidly growing neurodegenerative disorders, is characterized by a progressive loss of memory. Despite several advances in the field of medical therapeutics, a viable treatment for Alzheimer's disease would be of great importance. Medicinal plants represent a largely untapped reservoir of natural medicines and potential sources of anti-Alzheimer’s drugs. The structural diversity of their phytoconstituents makes these plants a valuable source of novel lead compounds in the quest for drugs to treat Alzheimer's disease.

Vascular Disease Alzheimer s Disease and Mild Cognitive Impairment

Vascular Disease  Alzheimer s Disease  and Mild Cognitive Impairment
  • Author : David J. Libon,Melissa Lamar,Rodney A. Swenson,Kenneth M. Heilman
  • Publisher : Oxford University Press
  • Release : 23 January 2020
GET THIS BOOK Vascular Disease Alzheimer s Disease and Mild Cognitive Impairment

Alzheimer's disease (AD) and vascular dementia (VaD) are commonly viewed as the first and second most common types of dementia, respectively. The traditional paradigm has been to view and treat each illness as a separate entity with a separate pathophysiology. However, clinical and pathological studies suggest that the boundary separating AD and VaD, as well as their mild cognitive impairment (MCI) analogs, is not well defined. Thus, there is increased interest in viewing these diseases along a spectrum because of

Novel Biomarkers in Alzheimer rsquo s Disease

Novel Biomarkers in Alzheimer rsquo s Disease
  • Author : Chiara Villa
  • Publisher : MDPI
  • Release : 05 February 2021
GET THIS BOOK Novel Biomarkers in Alzheimer rsquo s Disease

Alzheimer’s disease (AD) represents the most common form of dementia in the elderly population worldwide. AD is characterized by progressive neurodegeneration that leads to a gradual deterioration of memory and other cognitive functions. Given the global prevalence and impact of AD, there is a critical need to establish biomarkers that can be used to detect AD in individuals before the onset of clinical signs and provide mitigating therapeutics. The aim of this Special Issue is to discuss the current

Nanobiotechnology in Diagnosis Drug Delivery and Treatment

Nanobiotechnology in Diagnosis  Drug Delivery and Treatment
  • Author : Mahendra Rai,Mehdi Razzaghi-Abyaneh,Avinash P. Ingle
  • Publisher : John Wiley & Sons
  • Release : 02 December 2020
GET THIS BOOK Nanobiotechnology in Diagnosis Drug Delivery and Treatment

Presents nanobiotechnology in drug delivery and disease management Featuring contributions from noted experts in the field, this book highlights recent advances in the nano-based drug delivery systems. It also covers the diagnosis and role of various nanomaterials in the management of infectious diseases and non-infectious disorders, such as cancers and other malignancies and their role in future medicine. Nanobiotechnology in Diagnosis, Drug Delivery and Treatment starts by introducing how nanotechnology has revolutionized drug delivery, diagnosis, and treatments of diseases. It

Emerging Electromagnetic Technologies for Brain Diseases Diagnostics Monitoring and Therapy

Emerging Electromagnetic Technologies for Brain Diseases Diagnostics  Monitoring and Therapy
  • Author : Lorenzo Crocco,Irene Karanasiou,Michael L James,Raquel Cruz Conceição
  • Publisher : Springer
  • Release : 10 March 2018
GET THIS BOOK Emerging Electromagnetic Technologies for Brain Diseases Diagnostics Monitoring and Therapy

This timely book presents innovative technologies for use in the diagnosis, monitoring, and treatment of brain disease. These technologies offer exciting possibilities in the medical field owing to their low-cost, portability and safety. The authors address cerebrovascular diseases such as stroke, ischemia, haemorrhage, and vasospasm, these diseases having an ever-increasing societal relevance due to the global ageing population. The authors describe the potential of novel techniques such as microwave imaging and present innovative modalities for treatment of brain tumours using

Design of Nanostructures for Theranostics Applications

Design of Nanostructures for Theranostics Applications
  • Author : Alexandru Mihai Grumezescu
  • Publisher : William Andrew
  • Release : 15 January 2018
GET THIS BOOK Design of Nanostructures for Theranostics Applications

Design of Nanostructures for Theranostics Applications focuses on the theranostics applications of nanostructures. In particular, multifunctional nanoparticles for diagnostics and treatment of different diseases, including those relating to the blood-brain barrier, are discussed in detail. Chapters explore different type of nanostructures, covering design, fabrication, functionalization and optimization, helping readers obtain the desired properties. Written by a diverse range of international academics, this book is a valuable reference resource for those working in both nanoscience and the pharmaceutical industry. Explores how

Core Shell Nanostructures for Drug Delivery and Theranostics

Core Shell Nanostructures for Drug Delivery and Theranostics
  • Author : Maria Focarete,Anna Tampieri
  • Publisher : Woodhead Publishing
  • Release : 29 June 2018
GET THIS BOOK Core Shell Nanostructures for Drug Delivery and Theranostics

Core-Shell Nanostructures for Drug Delivery and Theranostics: Challenges, Strategies and Prospects for Novel Carrier Systems contains valuable chapters that deal with the fundamentals of nanotechnology for drug delivery, recent developments and research in core-shell nanoparticles for drug-delivery and theranostic applications, and the potential and applications of core-shell nanofiber. This book is a highly valuable resource for scientists interested in the design and development of innovative drug delivery systems, researchers and graduate/postdoctoral students engaged in biomaterials for drug delivery, and

Biogenic Nanoparticles for Cancer Theranostics

Biogenic Nanoparticles for Cancer Theranostics
  • Author : Chittaranjan Patra,Irshad Ahmad,Muhammad Ayaz,Ali Talha Khalil,Sudip Mukherjee,Muhammad Ovais
  • Publisher : Elsevier
  • Release : 01 June 2021
GET THIS BOOK Biogenic Nanoparticles for Cancer Theranostics

Biogenic Nanoparticles for Cancer Theranostics outlines the synthesis of biogenic nanoparticles to become cancer theranostic agents. The book also discusses their cellular interaction and uptake, pharmacokinetics, biodistribution, drug delivery efficiency, and other biological effects. Additionally, the book explores the mechanism of their penetration in cancerous tissue, its clearance, and its metabolism. Moreover, the in vitro and in vivo toxicological effects of biogenic nanoparticles are discussed. This book is an important reference source for materials scientists and biomedical scientists who are

Theranostics An Issue of PET Clinics E Book

Theranostics  An Issue of PET Clinics   E Book
  • Author : Ali Gholamrezanezhad,Hojjat Ahmadzadehfar
  • Publisher : Elsevier Health Sciences
  • Release : 07 June 2021
GET THIS BOOK Theranostics An Issue of PET Clinics E Book

This issue of PET Clinics focuses on Theranostics and is edited by Drs. Ali Gholamrezanezhad and Hojjat Ahmadzadehfar. Articles will include: Good Clinical Practice for Theranostics; Theranostics in Neuroendocrine Tumors; Neuroendocrine Tumors: Imaging Perspective; Prostate Cancer Theranostics: From Target Description to Imaging; Prostate Cancer Theranostics: PSMA-targeted Therapy; Theranostics in Brain Tumors; Theranostics in Neuroblastoma; Theranostics in Thyroid Cancer; and more!